Share this article and save a life!
Everyone thinks MSK software is boring. Flagler Health just proved it isn’t. 🔥
The conventional take on musculoskeletal health tech is that it’s a sleepy, commoditized corner of the market. Scheduling tools, basic EMR plugins, nothing worth getting excited about.
That take is wrong.
Flagler Health just closed a $50 million Series B, bringing its total raised to $63 million. And the people who wrote the checks are not exactly known for backing boring companies.
💡 Who they are: Flagler Health is an AI-native platform that coordinates clinical and administrative workflows for musculoskeletal healthcare providers. Think orthopedics, physical therapy, spine care. They plug directly into providers’ existing EMRs, which means no rip-and-replace, no massive implementation project, no reason to say no. According to AlleyWatch, the company was founded in 2022 by Albert Katz, Leon Anijar, and Will Hu, all of whom had actually run MSK clinics before building software for them. That matters more than most people realize.
📊 The funding breakdown:
🔹 Series B: $50 million, announced August 11, 2026
🔹 Lead investor: Bessemer Venture Partners
🔹 Participating investors: SignalFire, Alumni Ventures, Streamlined Ventures, 186 Ventures, PROOF, Tribeca Venture Partners, and Offscript
🔹 Total raised to date: $63 million
When Bessemer leads a healthtech round and SignalFire shows up alongside them, that is not a courtesy check. That is conviction.
🔎 Why this matters: Musculoskeletal care is described by SignalBase as one of healthcare’s largest and most fragmented specialties. Yet most of the AI investment has flooded into radiology, primary care, and revenue cycle. Flagler is betting that fragmentation is the opportunity, not the obstacle. They are building the connective tissue across the full patient lifecycle inside specialty clinics that have never had a real operating system.
The bigger picture here is that AI-native platforms built by operators are starting to pull away from generic workflow tools. Founders who have lived the problem are building more precisely than anyone coming in from the outside. Bessemer sees that. I see it too.
At Oatmeal Health, we work inside one of the most underserved, overlooked populations in healthcare. I understand the Flagler story because we live a version of it. The market does not reward complexity solved elegantly until someone proves it can be done. Then suddenly everyone notices.
If you track where the next wave of specialty-specific AI platforms is being built, save this post. The pattern is going to repeat across dozens of specialties over the next 24 months.
Flagler Health is an early proof point that specialty AI, done by operators, with real venture conviction behind it, is one of the most interesting bets in healthcare right now.
👉 Follow Jonathan Govette, CEO of Oatmeal Health, for daily healthcare insights on LinkedIn. Deeper dives in The Oatmeal Bite on Substack: https://news.oatmealhealth.com
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
